Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sotera Health Company Common Stock (SHC) vs Solstice Advanced Materials Inc. Common Stock (SOLS) Price & Performance

Sotera Health Company Common StockTrade
Solstice Advanced Materials Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Sotera Health Company Common Stock vs Solstice Advanced Materials Inc. Common Stock — how do they compare? Sotera Health Company Common Stock trades at $17.68 (market cap $5.06B), while Solstice Advanced Materials Inc. Common Stock trades at $59.92 (market cap $9.55B). The key difference: Solstice Advanced Materials Inc. Common Stock is the larger of the two by market cap, and Solstice Advanced Materials Inc. Common Stock pays a 0.5% dividend while Sotera Health Company Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sotera Health Company Common Stock for 0 Days and Solstice Advanced Materials Inc. Common Stock for 0 Days on average.

SHCSOLS
Market Cap
$5.06B$9.55B
Volume
2,279,7152,661,277
Sector
HealthBasic Materials
52-Week High
$19.57$88.60
52-Week Low
$13.13$41.43
Typical Hold Time
0 Days0 Days
Enterprise Value
$6.97B$11.23B
Dividend Yield
—0.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sotera Health Company Common Stock

No Aura AI signal available yet.

Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials (SOLS) trades at $60.91, up 0.33% with neutral technical signals. The company shows strong profitability with 30.64% gross margins and 14.95% ROE, though Q4 2025 earnings missed expectations. Recent developments include a $49M R&D expansion and termination of the Element Solutions merger, with the board authorizing a $500M share repurchase program. Analyst consensus is bullish with 80% buy ratings and a $80.22 price target representing 32% upside potential.

SOLS presents a compelling growth story with consistent earnings beats and institutional accumulation, though elevated P/E of 46.07 warrants caution. Key risks include execution challenges post-merger termination and margin pressure as profit margins declined from 6.09% to 5.12% year-over-year. The stock offers substantial upside if management delivers on growth initiatives while maintaining current profitability levels.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SHC
100% Buy0% Sell
Avg holding period · 0 Days
SOLS
100% Buy0% Sell
Avg holding period · 0 Days

About Sotera Health Company Common Stock

Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.

Read more on SHC →

About Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials Inc. is a specialty materials company spun off from Honeywell in 2025, producing low-global-warming-potential refrigerants, blowing agents, and industrial solvents through its Refrigerants and Applied Solutions segment. Its Electronic and Specialty Materials segment supplies semiconductor materials, high-strength fibers, and healthcare-packaging films.

Read more on SOLS →